Should patients with hepatitis C genotype 2/3 infection who are slow responders to pegylated interferon/ribavirin have treatment duration extended?
| Image |  |
|---|---|
| Description | scientific article published on 7 November 2014 |
| Author/s |
author: Joshua S. Davis |
| Publication date | June 12, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |